RASTETTER WILLIAM H Insider Trades

Insider Trading History

Track insider trading activity for RASTETTER WILLIAM H. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $190k 87,900 shares
Last Trade
Jun 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181k 87,900 shares
$2.06
$2.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $414k 2,567 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,567 shares
$155.83
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $7.05M 43,678 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$161.44
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $78.5k 36,331 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $0 0 shares
Last Trade
May 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$59k 25,000 shares
$2.36
$2.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
Nov 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.77M 18,000 shares
$153.75
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $9.42M 58,360 shares
Last Trade
Nov 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.77M 18,000 shares
$153.75
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $6.52M 40,360 shares
Last Trade
Nov 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.73M 18,000 shares
$151.82
$161.44
Dare Bioscience
Dare Bioscience DARE
Director
Holding Value $9.32k 4,500 shares
Last Trade
Jul 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11k 4,500 shares
$2.44
$2.07
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $0 0 shares
Last Trade
Jun 25, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.02M 124,975 shares
$8.16
$8.16
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $468k 57,292 shares
Last Trade
Jun 25, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$361k 44,264 shares
$8.16
$8.16
Fate Therapeutics
Fate Therapeutics FATE
Director
Holding Value $119k 55,000 shares
Last Trade
May 29, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$72.6k 55,000 shares
$1.32
$2.16
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $6.52M 40,360 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $536k 3,318 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 3,318 shares
$120.56
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $6.05M 37,491 shares
Last Trade
May 05, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.31M 30,000 shares
$110.20
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $10.9M 67,491 shares
Last Trade
May 05, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.29M 30,000 shares
$109.75
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 05, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.29M 30,000 shares
$109.75
$161.44
Regulus Therapeutics
Regulus Therapeutics RGLS
Director
Holding Value $829k 101,556 shares
Last Trade
Apr 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$499k 62,500 shares
$7.98
$8.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up